AccuStem Sciences, Inc.
ACUT
$0.28
-$0.04-12.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.63% | 0.37% | 8.86% | -18.36% | -13.38% |
| Total Depreciation and Amortization | -- | -100.00% | -66.67% | -66.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 2.16% | -76.11% | -61.54% | 1,243.09% |
| Change in Net Operating Assets | 325.14% | -157.03% | 656.82% | -55.67% | 31.60% |
| Cash from Operations | 103.71% | -2,896.76% | 107.44% | -72,650.00% | 100.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | 0.00% | 14.29% | -4.31% | 21.30% | -37.29% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -103.88% | 2,307.52% | -108.27% | 1,092.28% | -115.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.06% | -240.00% | -115.97% | 197.81% | -255.56% |